Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
Price:
999 999.9999 JPY
Market Closed
Updated:
Apr 29, 2024
Taisho Pharmaceutical Holdings Co Ltd
Net Income (Common)
|
Taisho Pharmaceutical Holdings Co Ltd
Net Income (Common) Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Taisho Pharmaceutical Holdings Co Ltd
TSE:4581
|
Net Income (Common)
¥8.4B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-13%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Net Income (Common)
¥178.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
10%
|
CAGR 10-Years
2%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Net Income (Common)
¥186.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
23%
|
CAGR 10-Years
5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Net Income (Common)
¥121.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-4%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Net Income (Common)
¥325.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
29%
|
CAGR 10-Years
20%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Net Income (Common)
¥37.3B
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-9%
|
See Also
What is Taisho Pharmaceutical Holdings Co Ltd's Net Income (Common)?
Net Income (Common)
8.4B
JPY
8.4B
JPY
Based on the financial report for Dec 31, 2023, Taisho Pharmaceutical Holdings Co Ltd's Net Income (Common) amounts to 8.4B JPY.
What is Taisho Pharmaceutical Holdings Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-13%
-13%
Over the last year, the Net Income (Common) growth was -66%. The average annual Net Income (Common) growth rates for Taisho Pharmaceutical Holdings Co Ltd have been -20% over the past three years , -32% over the past five years , and -13% over the past ten years .
You don't have any saved screeners yet
